AbbVie Inc and Shire PLC’s US$54.8 billion deal is set to make AbbVie the largest US company to move its legal address abroad, which would lower its taxes, as US lawmakers seek ways to curb similar transactions.
Shire shareholders are to get cash and stock valued at US$89.67 a share, the companies said on Friday in a statement.
It would allow Chicago-based AbbVie to move its legal residence, though not its operations, to the UK, lowering its tax rate in 2016 to 13 percent from 22 percent.
“This is a transaction that we believe has excellent strategic fit, well beyond the tax impact,” AbbVie chief executive officer Richard Gonzalez said during a conference call.
At the same time, Gonzalez said the higher corporate tax rate in the US is pushing companies abroad.
“Companies like ours need access to our global cash flows,” he said. “Today we’re at a disadvantage compared to our foreign competitors, and that’s the debate we should be having around inversions and our tax code.”
The US government has been scrutinizing so-called tax inversions, and Senator Ron Wyden, a democratic representative from Oregon, is proposing a bill that would make the process more difficult.
A congressional panel estimated this year that preventing future inversions would save US$19.5 billion in otherwise forgone tax revenue over the next 10 years.
Gonzalez said government action to stop tax inversions probably would not halt the Shire deal.
“We’ve looked carefully at that aspect and we believe its executable,” he said.
Every deal that gets done, though, puts pressure on the US government to act, said Brian Corvino, an analyst with Decision Resources Group.
In negotiations, Shire sought protection in case the US passes a law undercutting the tax gains and puts closing the deal at risk, said two people with knowledge of the matter.
The agreement calls for AbbVie to pay Shire a breakup fee of 3 percent of the deal’s value, about US$1.6 billion, or reimburse costs of not less than US$500 million, if the purchase falls through, according to the statement.
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Taiwan is open to joining a global liquefied natural gas (LNG) program if one is created, but on the condition that countries provide delivery even in a scenario where there is a conflict with China, an energy department official said yesterday. While Taiwan’s priority is to have enough LNG at home, the nation is open to exploring potential strategic reserves in other countries such as Japan or South Korea, Energy Administration Deputy Director-General Chen Chung-hsien (陳崇憲) said. While the LNG market does not have a global reserve for emergencies like that of oil, the concept has been raised a few times —
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday received government approval to deploy its advanced 3-nanometer (3nm) process at its second fab currently under construction in Japan, the Ministry of Economic Affairs said in a news release. The ministry green-lit the plan for the facility in Kumamoto, which is scheduled to start installing equipment and come online in 2028 with a monthly production capacity of 15,000 12-inch wafers, the ministry said. The Department of Investment Review in June 2024 authorized a US$5.26 billion investment for the facility, slated to manufacture 6- to 12nm chips, significantly less advanced than 3nm process. At a meeting with
Standard Chartered Taiwan on March 26 announced that it has partnered with international fintech firm FinIQ to build an “Automated Structured Products Pricing Platform.” The bank is also introducing products from global issuers including Goldman Sachs Group Inc, Barclays PLC and BNP Paribas SA. The new platform enables an end-to-end process whereby it finds the most competitive pricing across multiple issuers in a matter of minutes, followed by automated documentation and transaction execution, which significantly shortens time-to-market and delivers a superior wealth management experience. Standard Chartered Bank Taiwan CEO Anthony Yu (游天立) said: “Standard Chartered is increasingly leveraging its wealth management
RSS